ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
30 hedge funds and large institutions have $22M invested in Acura Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
60% less call options, than puts
Call options by funds: $39K | Put options by funds: $98K
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
Holders
30
Holding in Top 10
1
Calls
$39K
Puts
$98K
Top Buyers
| 1 | +$84.9K | |
| 2 | +$65.5K | |
| 3 | +$60K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$35.8K |
| 5 |
Goldman Sachs
New York
|
+$22.5K |
Top Sellers
| 1 | -$307K | |
| 2 | -$217K | |
| 3 | -$148K | |
| 4 |
D.E. Shaw & Co
New York
|
-$143K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$105K |